Skip to content
Monday, November 16, 2026
Prime Collective

The Zimbabwean Government Rejects ‘Lopsided’ US Healthcare Assistance Agreement Over Data Concerns

Medical funding image
The offered American financial assistance was intended for programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has declined a substantial American healthcare agreement valued at 367 million US dollars (272 million pounds) over five years over the United States' demand for confidential biological samples.

The decision came to light after a internal memorandum dated December was leaked, which showed President Emmerson Mnangagwa felt the deal was "lopsided".

A government spokesman later clarified that the United States was requesting biological samples for scientific study and profit but was not willing to share the resulting advantages from any future vaccines.

"We must now begin the challenging and unfortunate process of ending our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has appealed for continued dialogue to secure a deal acceptable to both sides so the country's critical HIV programme can continue.

Broader Context

This rejection follows a similar case in neighbouring Kenya, where a court halted a related health funding agreement following concerns were filed about the safety of citizens' health data.

After resuming office last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).

The agency had administered aid for the American government, but Trump claimed its spending was "wasteful" and his administration was pursuing direct bilateral deals to enhance transparency and responsibility.

Based on reports, 16 nations in Africa have to date signed these new agreements, representing more than $18.3bn of fresh investment.

Specifics of the Rejected Agreement

The money for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We are confident this collaboration would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million presently on HIV treatment through US-supported initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".

"Our nation was requested to share its biological resources and data for a long time, without any equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.

"Effectively, our nation would supply the basic resources for scientific discovery with no certainty that the final treatments would be accessible to our population if a new disease outbreak arise."

National Interest and International Frameworks

He also noted that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were upending structures already set up through the international organization.

Mangwana gave as an example its Pandemic Benefit-Sharing framework designed to deal with future pandemics.

"This mechanism is designed to ensure that when a nation provides its samples, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the funds to create them."

The government's concerns over the US deal "are not meant as opposition to America," Mangwana stressed.

"We welcome further dialogue with our US partners on how future collaboration could be structured in a way that respects the independence and interests of both nations."

Medical Community Response

A leading public health body expressed it recognised the official position, but recommended that talks should continue given that much of the nation's HIV programmes depended on foreign aid.

"If specific concerns exist, such as those involving data governance or implementation frameworks, these can often be resolved through detailed discussion and mutually agreed protections," it said.

The halted deal underscores the continuing tensions between accepting crucial foreign assistance and safeguarding a country's data in an increasingly data-driven world.

LG
By

Laura Gamble

Alex is a creative director with over a decade of experience in branding and digital strategy, passionate about helping brands find their unique voice.

Prime Collective

Type to search articles.